703 results found

AMR is a major global challenge and is getting the attention of all relevant stakeholders. Factors such as inappropriate and irrational use of antimicrobial agents among others have led to the increase in AMR.

With each passing hour, the number of confirmed cases of COVID-19 in India is increasing rapidly.

On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.

This is the first and only treatment for nraxSpA approved by USFDA.

On October 24, 2018, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

The commission's aim is to identify innovative ways to curb the world's biggest causes of death and extend life expectancy for millions of people.

On July 05, 2018, the Council of Scientific and Industrial Research - Institute of Microbial Technology, a premier microbial institute under the aegis of the Ministry of Science and Technology, ...

Access to affordable medical care is a fundamental right of every human being. From the perspective of patent law, in India, generally the focus has been on pharmaceutical drugs and how patent law can balance the right of public to affordable drugs viz-a-viz the right of innovators.

In March 2020, the World Health Organisation declared COVID-19 a pandemic. This has caused employers around the world to take measures to protect and screen their employees and business contacts.

Cablivi was developed by Ablynx, a Sanofi company.

This segment of the newsletter focuses on sharing the recent regulatory reforms and updates on Healthcare and Pharmaceutical domain from World Health Organization (WHO).

Regulatory uncertainty concerning stem cell treatment in India has been a polarizing issue.

The National Medical Commission Act, 2019 (hereinafter referred to as ‘Act') came into force on August 08, 2019.

The Department of Pharmaceuticals recently released the draft Uniform Code of Medical Devices Marketing Practices on March 16, 2022 to regulate the marketing of medical devices by companies in India.

In the healthcare industry, trust and ethics are paramount. Patients rely on healthcare professionals to guide them through critical medical decisions, expecting that these recommendations...

The Competition Commission of India (CCI) in an order dated 13 August 2021 declined to initiate investigation into allegations of abuse of dominant position and anticompetitive vertical agreements against ...

COVID-19 has brought the world to its knees. Countries are at different stages of transmission of the pandemic, trying their best to cope with its growing economic and social impact.

The Scenario in the IPR sector has undergone vibrant change in the recent past. This change has not been restricted to the pharmaceutical sector alone, but has extended itself to other systems of Intellectual Property.